Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter:

“I am excited to share our latest work (and Ph.D.’s baby) with Neta Erez on breast cancer bone metastasis, showing how combining TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis. In Cancer Discovery.”

Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Proceed to the article.
Source: Lea Monteran/X

bone metastases Breast Cancer cancer Cancer Discovery Lea Monteran MDSC inhibition metastatic breast cancer Neta Erez OncoDaily Oncology Tel Aviv University TIGIT blockade